Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Alexion Pharmaceuticals, Inc.    ALXN   US0153511094

 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
10/20/2014 10/21/2014 10/22/2014 10/23/2014 10/24/2014 Date
168.2(c) 174.475(c) 173.27(c) 185.92(c) 190.29(c) Last
1 179 649 1 271 754 1 420 191 2 389 026 1 810 418 Volume
+2.09% +3.73% -0.69% +7.30% +2.35% Change
More quotes
Company
Alexion Pharmaceuticals, Inc. is a biopharmaceutical company, engages in the innovation, development, and commercialization of life-transforming therapeutic products for treating patients with severe and ultra-rare disorders.It focuses on developing products for the treatment of diseases in the... 
Sector
Pharmaceuticals
Calendar
02/12Earnings Release
Surperformance© rating of Alexion Pharmaceuticals, I
Trading Rating : Investor Rating :
More about the company
Chart ALEXION PHARMACEUTICALS, I
Duration : Period :
Alexion Pharmaceuticals, I Technical Analysis Chart | ALXN | US0153511094 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 2 218 M
EBIT 2014 1 102 M
Net income 2014 721 M
Finance 2014 1 746 M
Yield 2014 -
Sales 2015 2 709 M
EBIT 2015 1 344 M
Net income 2015 925 M
Finance 2015 2 885 M
Yield 2015 -
PER 2014 54,04
PER 2015 39,54
EV / Sales 2014 16,2x
EV / Sales 2015 12,8x
Capitalization 37 642 M
More Financials
Latest news on ALEXION PHARMACEUTICALS, I
1d ago ALEXION PHARMACEUTICALS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL COND..
1d ago ALEXION PHARMACEUTICALS : Biotech Stocks Technical Data - CytRx, Vertex Pharma, ..
2d ago ALEXION PHARMACEUTICALS : Results of Operations and Financial Condition, Financi..
2d ago ALEXION PHARMACEUTICALS : Researchers to Present Data on Soliris® (eculizumab) a..
2d ago ALEXION PHARMACEUTICALS : tops Street 3Q forecasts
2d ago ALEXION PHARMACEUTICALS : Reports Third Quarter 2014 Results
3d ago ALEXION PHARMACEUTICALS : Submits NDA in Japan for Asfotase Alfa as a Treatment ..
5d ago ALEXION PHARMACEUTICALS : Submits NDA for Asfotase Alfa
10/18 ALEXION PHARMACEUTICALS : to sponsor 2015 National Donor Memorial Award for Exce..
10/15 ALEXION PHARMACEUTICALS : to Report Third Quarter 2014 Results on Thursday, Octo..
10/15 ALEXION PHARMACEUTICALS : Submits NDA in Japan for Asfotase Alfa as a Treatment ..
10/13 NASDAQ 100 MOVERS : Tsla, vrtx
More news


Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF